Procedures for the evaluation of monoclonal immunoglobulins

Archives of Pathology and Laboratory Medicine

Volumn 123, Issue 2, 1999, Pages 126-132

  Keren, David F ^a  

^a Warde Medical Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

M PROTEIN; PARAPROTEIN; SULFOSALICYLIC ACID;

CAPILLARY ELECTROPHORESIS; CONFERENCE PAPER; HUMAN; HUMAN CELL; IMMUNOELECTROPHORESIS; ISOELECTRIC POINT; LABORATORY TEST; MONOCLONAL IMMUNOGLOBULINEMIA; NEPHELOMETRY; PARAPROTEINEMIA; QUALITY CONTROL; SCREENING; TECHNIQUE;

ELECTROPHORESIS; HUMANS; IMMUNOELECTROPHORESIS; IMMUNOGLOBULINS; LABORATORIES, HOSPITAL; PARAPROTEINEMIAS; QUALITY ASSURANCE, HEALTH CARE;

EID: 0032941970     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Keren DF. Methods and rationale for high-resolution electrophoresis. In: High-Resolution Electrophoresis and Immunofixation. 2nd ed. Boston, Mass: Butterworth Heinneman; 1994: chap 1.
2. Bienvenu I, Graziani MS, Arpin F, et al. Multicenter evaluation of the Paragon CZE 2000 capillary zone electrophoresis system for serum protein electrophoresis and monoclonal component typing. Clin Chem. 1998;44:599-605.
3. Jenkins MA, Guerin MD. Optimization of serum protein separation by capillary electrophoresis [letter). Clin Chem. 1996;42:1886.
4. Henskens Y, De Winter J, Pekelharing M, Ponjee G. Detection and identification of monoclonal gammopathies by capillary electrophoresis. Clin Chem. 1998;44:1184-1190.
5. College of American Pathologists. SURVEY Report EC-07. Northfield, Ill: College of American Pathologists; 1991.
6. Kyle RA. "Benign" monoclonal gammopathy: after 20 to 35 years of follow-up. Mayo Clin Proc. 1993;63:26-36.
7. Su L, Keren DF. The effects of exogenous free fatty acids on lipoprotein migration in serum high-resolution electrophoresis: addition of free fatty acids improves visualization of normal and abnormal alpha1-antitrypsin. Am J Clin Pathol. 1998;109:262-267.
8. Keren DF, Warren JS, Lowe JB. Strategy to diagnose monoclonal gammopathies in serum: high-resolution electrophoresis, immunofixation, and quantification. Clin Chem. 1988;34:2196-2201.
9. Bush D, Keren DF. Over- and underestimation of monoclonal gammopathies by quantification of kappa and lambda containing immunoglobulins in serum. Clin Chem. 1992;38:315-316.
10. Vrethem M, Larsson B, von Schenck H, Ernerudh J. Immunofixation superior to plasma agarose electrophoresis in detecting small M-components in patients with polyneuropathy. J Neurol Sci. 1993;120:93-98.
11. Keren DF. Immunofixation technique. High-Resolution Electrophoresis and Immunofixation. 2nd ed. Boston, Mass: Butterworth Heinneman; 1994:chap 6.
12. Register LJ, Keren DF. Hazard of commercial antiserum cross-reactivity in monoclonal gammopathy evaluation. Clin Chem. 1989;35:2016-2017.
13. Alexander RL Jr, Roodman ST, Petruska PJ, Tsai CC, Janney CG. A new case of IgE myeloma. Clin Chem. 1992;38:2328-2332.
14. Keren DF. Capillary zone electrophoresis in the evaluation of serum protein abnormalities. Am J Clin Pathol. 1998;110:248-252.
15. Sun T, Peng S, Narurkar L. Modified immunoselection technique for definitive diagnosis of heavy chain disease. Clin Chem. 1994;40:664.
16. Levinson SS, Keren DF. Free light chains of immunoglobulins: clinical laboratory analysis. Clin Chem. 1994;40:1869-1878.
17. Keren DF. Quantitative, Electrophoretic and Immunochemical Characterization of Immunoglobulins and Serum Proteins. Blackwell; 1998. In press.
18. Keren DF. Clinical indications for electrophoresis and immunofixation. In: Rose N, Conway de Macario E, Folds JD, Lane HC, Nakamura RM, eds. Manual of Clinical Immunology. Washington, DC: ASM Press; 1997:65-74.